Background/ Aim. Recent studies have shown that process of aortic calcification is often
Introduction
As the life expectancy is getting longer, there is an increasing number of patients with calcific aortic stenosis. It is estimated that the number of patients is even greater than the known statistical estimates, since the patients only report in the late stage of the disease, when symptoms are pronounced, and prognosis is worse. Knowing the possible risks and mechanisms of the occurrence of the disease would allow early diagnosis and treatment of these patients, possibly non-surgical. The question arises whether the development of bone and cartilage tissue is a common process or occurs in predisposed patients.
Calcification is a frequent change in aortic cusps and the most common cause of aortic valve stenosis. It is closely related to aging and is thought to be a consequence of the sustained mechanical stress, when calcification occurs within the collagen of the fibrous zone. It also occurs in association with rheumatic valvular disease and bicuspid aorta. 1, 2 It has long been thought that calcification is an exclusively passive process. However, recent studies have shown that this process is often active and closely related to the formation of bone tissue in calcific aortic stenosis. It means the inflammation and the existence of 5 progenitor cells that differ in certain conditions in osteoblasts. 3, 4 Calcium leads to rigidity of the valve, and stenosis of the aortic mouth.
The aim of our work was to analyze the demographic characteristics of patients with calcified aortic stenosis, the most common symptoms of the disease, the presence of comorbidities and risk factors, as well as to examine the frequency of bone and cartilage metaplasia in calcific aortic valve stenosis and its possible association with the present comorbidities. We also aimed to discover a clinical importance of metaplasia in calcific aortic stenosis.
Methods
The study included 115 patients with replacement of the aortic valve during the period from January 2013 to December 2015 at the University Hospital due to diagnosed calcified aortic stenosis. Furthermore, in some of the patients, revascularization (CABG), thrombanderterectomy (TEA), replacement of the ascending aorta, mitral and tricuspid valve anuloplasty, patch plastics of the interstitial septum or atrial septal defect closure (ASD closure) have been performed in addition to aortic valve replacement (AVR). The material for pathohistological analysis was processed and analyzed in the Pathology Center, and demographic and clinical-morphological data included in the research were:
age, sex, existing comorbidities, risk factors, disease symptoms, aortic valve area obtained by Doppler and measured in cm 2 (AVA), and histological type of metaplasia in aortic valve.
The only criteria for inclusion in the study were surgery: aortic valve replacement or myocardial revascularization with aortic valve replacement. Data for all patients are from the history of the disease and pathohistological referrals. The exclusion criterion was a possible lack of data from the medical records. 
Results
The study covered 115 patients with diagnosed calcific aortic stenosis.
Age and gender distribution
Patients were aged 24 to 83 years. The average age of the examined patients was 67.3 years (Fig. 1) 
Presence of metaplasia
Of all patients with calcified aortic stenosis, in 17 (14.8%) patients, the presence of bone and / or cartilage tissue in aortic cusps was found ( Table 2 , Fig. 2, Fig. 3, Fig. 4 
Discussion
Calcification is a frequent change in aortic cusps and the most common cause of aortic valve stenosis. Possible initiators of this pathological process are abnormal haemodynamic forces in hypertension and increased stretching of cusps that initiate the remodeling process and inflammation, further leading to calcification and valvular ossification. has been proven to be dependent on alkaline phosphatase activity. 9 The presence of hydroxyapatite, osteopontin, bone sialoprotein, BMP-2 and osteocalcin has been detected in calcified valves, suggesting that calcification is not a passive degenerative process, but an active process that implies the existence of an osteoblast cellular phenotype. 4 There are some similarities between the process of calcification and atherosclerosis.
It has been proven that patients with aortic sclerosis have a 40% higher risk of myocardial infarction and a 50% greater chance of sudden cardiac death. A possible explanation is that aortic sclerosis is an indicator of the developing process of atherosclerosis in the body, namely, atherosclerosis and aortic sclerosis are two manifestations of one and the same disease. According to literature data age, male sex, smoking, hypertension and hyperlipidemia are risk factors for both aortic sclerosis and atherosclerosis, which supports this theory. 10, 11 Our results are in line with the literature, given that calcified aortic stenosis in our patients was more common among men, most often in the seventh decade of life.
The highest value of systolic blood pressure among our patients was 190 mm Hg and diastolic 120 mm Hg. The average blood pressure was 140/83 mm Hg. Blood pressure was measured at the moment of hospital admission. Among our patients, as opposed to literature, there were more non-smokers. This has to be interpreted bearing in mind the fact that the most people in Serbia are non smokers, and not in direction of excluding smoking as risk factor.
LDL, ACE converting enzyme and its product-angiotensin II18 were found in the interstititium of calcified cusps, and even in the macrophages themselves. 12 Although there is a possibility that part of the ACE is produced in the cusps itself, most of it is still extracellular and occurs in the presence of apolipoprotein B, suggesting the possibility that 10 ACE in the lesion has been linked to LDL particulates. 12 The results of our research have shown that most of affected patients are overweight. Since obesity, as part of the metabolic syndrome is associated with increased production of LDL particles and increased production of inflammatory cytokines, our results support the assumptions that these events are likely to be part of the pathomechanism that leads to calcified aortic stenosis. 13, 14, 15 Howewer, in our study BMI had the same distribution among patients with moderate, severe and critical aortic stenosis. Also, high blood glucose level enhances valve interstitial cell (VIC) matrix calcium deposition. 15 An interesting fact is that diabetes mellitus reduces the occurrence of ossification in calcified altered valves. 16 Recent studies have shown a high association of Warfarin therapy and the occurrence of aortic valvular calcification. 17, 18 Warfarin leads to calcification influencing the synthesis and function of the matrix Gla-protein, which is otherwise an inhibitor of the calcification process. 16, 18 Taking everything mentioned together, it might be that the haemodynamic and mechanical forces along with oxidized lipids and exogenous substances (e.g., bacterial lipopolysaccharides) transform calm VICs into activated VICs. 19 34 This study also shows more frequent reporting of metaplasia in males, which is in line with our results.
In our study in patients with pathohistologically proven metaplasia, the presence of yellow bone marrow was more common, which corresponds to the results of other studies on this topic. 35 Metaplasia was equally prevalent among patients with moderate, severe and critical aortic valve stenosis, which may point out that metaplasia has no influence on severity of aortic valve stenosis. It is still a question whether metaplasia is just a patologic finding or it has some influence on clinical course of disease. However, greater sample is required to discover it.
To this date, no medical therapy has been proven to prevent or to stop the progression of aortic valve stenosis. Although it was tried to find another, the only therapeutic approach for now is aortic valve replacement. 36, 37 In order to develop the new treatment strategies, we have to discover the complex pathophysiological pathway of this disease.
Conclusions
Age, sex, smoking, body mass index and blood pressure values show the same distribution among patients with and without pathohistologically proven metaplasia, which may point out that these are not risk factors for metaplasia among patients with calcific 12 aortic stenosis. Metaplasia shows no impact on severity of disease. Howewer, further studies are required to show whether there are specific risk factors that lead to metaplasia and is it connected with the late stage and worse outcome of disease. Fig. 1 . Age distribution among patients. .
